Blood coagulation or clotting is the process by which blood changes from liquid to gel, thus, forming clots. These clots result in cessation of bleeding. However, the process of coagulation is hindered in the people suffering from liver disease, thrombophilia, and hemophilia. Various blood coagulation testing procedures are used for diagnosing these diseases, which provide the status of the hemostatic functioning of the patient. Haemostatic involves a coordinated series of interactions between platelets and numerous blood clotting proteins. With increasing prevalence of hemostatic diseases, the demand for blood coagulation testing has increased. To analyses the treatment efficiency against hemostatic diseases, the blood clotting testing is required.

The global Blood Coagulation Testing market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blood Coagulation Testing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Coagulation Testing market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood Coagulation Testing in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood Coagulation Testing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Alere
Siemens Healthcare
Accriva Diagnostics
CoaguSense
HomoSonics
iLine Microsystems
Instrumentation Laboratory
Sienco
SenGenix
Bio/Data Corporation

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Clinical Laboratory
Automated

Segment by Application
Academic Institutions
Hospitals